BR100 Increased By (0.2%)
BR30 Increased By (0.41%)
KSE100 Increased By (0.07%)
KSE30 Increased By (0.23%)
AGHA 7.75 Decreased By ▼ -0.17 (-2.15%)
BECO 5.19 Decreased By ▼ -0.01 (-0.19%)
BML 58.66 Decreased By ▼ -0.59 (-1%)
BOP 33.69 Increased By ▲ 0.01 (0.03%)
CNERGY 10.61 Increased By ▲ 0.80 (8.15%)
CSIL 5.30 Decreased By ▼ -0.12 (-2.21%)
FCCL 53.74 Increased By ▲ 0.22 (0.41%)
FFL 16.46 Decreased By ▼ -0.22 (-1.32%)
FNEL 1.22 Increased By ▲ 0.01 (0.83%)
KEL 7.28 Decreased By ▼ -0.07 (-0.95%)
KOSM 5.64 Increased By ▲ 0.03 (0.53%)
LOTCHEM 29.65 Increased By ▲ 0.54 (1.86%)
MLCF 96.36 Increased By ▲ 0.86 (0.9%)
NBP 203.53 Decreased By ▼ -0.82 (-0.4%)
NCPL 56.85 Decreased By ▼ -1.39 (-2.39%)
NPL 67.31 Decreased By ▼ -0.48 (-0.71%)
OGDC 318.22 Increased By ▲ 0.28 (0.09%)
PACE 10.63 Decreased By ▼ -0.08 (-0.75%)
PAEL 41.77 Decreased By ▼ -0.06 (-0.14%)
PIBTL 16.81 Increased By ▲ 0.31 (1.88%)
PPL 220.17 Increased By ▲ 0.43 (0.2%)
PRL 49.05 Increased By ▲ 4.46 (10%)
PTC 70.01 Decreased By ▼ -0.76 (-1.07%)
SSGC 29.14 Increased By ▲ 0.21 (0.73%)
TBL 9.77 Decreased By ▼ -0.07 (-0.71%)
TELE 8.82 Increased By ▲ 0.06 (0.68%)
TPL 17.17 Increased By ▲ 0.72 (4.38%)
TPLP 12.51 Increased By ▲ 0.41 (3.39%)
TREET 22.59 Decreased By ▼ -0.21 (-0.92%)
TRG 60.22 Increased By ▲ 0.19 (0.32%)
By

NEW YORK: Wall Street’s main indexes were flat to higher in choppy trading on Friday, with the Nasdaq reversing earlier losses as megacap tech stocks regained ground, while investors also assessed stronger-than-expected US business activity data.

Megacaps Microsoft Alphabet, Amazon.com and Apple rose between 0.7% and 2%, lifting the tech-heavy Nasdaq and helping the S&P 500 pare early losses.

The S&P 500 Technology index reversed early losses, rising 0.1%, while financial stocks were the biggest decliner.

All the three major Wall Street indexes were on track to post weekly gains, with the S&P 500 briefly crossing the 5,500-point milestone during Thursday’s session.

US business activity crept up to a 26-month high in June amid a rebound in employment, but price pressures subsided considerably, offering hope that a recent slowdown in inflation was likely to be sustained.

Flash services PMI increased to 55.1 this month, above expectations of 53.7, while manufacturing PMI edged up to 51.7, compared with expectations of a dip to 51.

May home sales fell to a seasonally adjusted annual rate of 4.11 million units versus expectations of 4.10 million units.

The market is also assessing a string of weakening economic data, and commentary from US Federal Reserve officials this week that interest rates could remain higher for longer if there is no consistent improvement in inflation numbers.

“It certainly looks like at this point the Fed is going to hold tight for a while ... the market is slowly adjusting to that reality,” said Lamar Villere, portfolio manager with Villere & Co.

Money markets are still pricing in a 58% chance of a 25-basis point rate cut in September, and still expect about two rate cuts this year, according to LSEG’s FedWatch data.

AI chip firm Nvidia slipped 0.5%, while semiconductor stocks Qualcomm, Broadcom and Micron Technology were down between 0.2% and 2%.

Wall Street’s bumper gains since the final leg of 2023 have been primarily driven by the likes of Nvidia and a handful of other heavily weighted stocks linked to artificial intelligence. Analysts, however, have raised concerns whether the strong increase in their valuations is sustainable.

Friday’s session will mark the expiry of quarterly derivatives contracts tied to stocks, index options and futures, also known as “triple witching”, adding to market volatility.

At 12:12 p.m. ET, the Dow Jones Industrial Average was down 9.57 points, or 0.02%, at 39,125.19, the S&P 500 was up 2.04 points, or 0.04%, at 5,475.21, and the Nasdaq Composite was up 45.86 points, or 0.26%, at 17,767.44.

Spirit AeroSystems rose 6.1% following a Reuters report that Boeing is nearing a deal to buy back the airplane parts supplier after months of talks.

Sarepta Therapeutics soared 35.2% after the US FDA allowed expanded use of the company’s gene therapy for patients with Duchenne muscular dystrophy aged four and older.

Comments

Comments are closed for this article.